Gibbeum General Hospital
Diabetes type 2 treatment cost in Republic of Korea typically involves specialized diagnostics like retinal nerve fiber layer measurement (RNFL) ranging from $100 to $200 and primary surgical interventions. Advanced metabolic surgery runs from $12,500 to $21,500, with total expenses depending on disease complications and hospital tier. Patients can see 30-50% savings compared to the US. Top cities include Seoul and Cheonan.
Typical Diabetes Type 2 Treatment Costs in Republic of Korea
Bookimed Expert Insight: For patients with morbid obesity and type 2 diabetes, metabolic surgery is a highly effective option. Soon Chun Hyang University Hospital features Dr. Yongjin Kim, a world-renowned "Master Surgeon" with over 2,000 bariatric procedures. Advanced cases benefit from multidisciplined care at Joint Commission International (JCI) accredited centers like Asan Medical Center. Specialized arterial stem cell therapy is also available at RE:YOUTH for targeted patient needs.
| Republic of Korea | Turkey | Austria | |
| Metabolic surgery | from $12,500 | from $4,140 | from $17,000 |
| Gastric band | from $7,200 | from $4,275 | from $14,000 |
| Bioidentical hormone replacement therapy (BHRT) | from $850 | from $800 | from $1,800 |
| Stem cell for diabetes | - | from $12,000 | from $25,000 |
| Biliopancreatic diversion | - | from $5,348 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Diabetes type 2 treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Diabetes type 2 treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Diabetes type 2 treatment journey.
Performed over 2,000 bariatric surgeries – recently named Korea's first 'Master Surgeon' by the American Surgical Review Corporation.
The doctor is a leading neurologist in South Korea, specializing in epilepsy treatment. Currently, the doctor serves as the Head of the Neurology Department at Yonsei Severance Hospital.
The doctor graduated from Yonsei University College of Medicine and is an active member of several professional organizations, including The Korean Epilepsy Society, The Korean Neurological Association, and The Korea Medical Association.
Metformin has historically been the primary first-line medication for Type 2 diabetes in South Korea. However, 2025 Korean Diabetes Association (KDA) guidelines now favor individualized therapy. Doctors select initial treatments like SGLT2 inhibitors or GLP-1 agonists based on heart health, kidney function, and obesity status.
Bookimed Expert Insight: While metformin remains a foundational tool, our data shows a shift toward metabolic surgery as a definitive intervention for Type 2 diabetes. Professor Dr. Yongjin Kim at Soon Chun Hyang University Hospital has performed over 2,000 bariatric procedures. This high surgical volume reflects a growing trend in Seoul where clinical expertise focuses on long-term remission alongside standard pharmacological management.
Patient Consensus: Patients note it is common to receive two or three drugs simultaneously rather than waiting for one to fail. Many emphasize reporting gastrointestinal side effects from metformin early to ensure doctors can adjust the dosage quickly.
GLP-1 receptor agonists and SGLT2 inhibitors are the leading medications for managing weight and cardiovascular health in Type 2 diabetes. Options like semaglutide and tirzepatide offer up to 22.5% weight reduction while lowering major cardiac event risks by 20% in clinical settings.
Bookimed Expert Insight: South Korea’s medical infrastructure offers a unique integration of pharmaceutical and surgical expertise. While GLP-1 medications are popular, the high volume of metabolic surgeries at centers like Soon Chun Hyang University Hospital—where Dr. Yongjin Kim has performed 2,000+ procedures—shows a preference for long-term weight solutions when medication alone is insufficient.
Patient Consensus: Patients note it's important to start with low doses to manage stomach sensitivity. Many suggest combining these new medications with probiotics to help with gut tolerance during the first few months.
Foreigners access Type 2 diabetes care in South Korea through specialized international clinics at JCI-accredited tertiary hospitals. Facilities like Severance Hospital and Asan Medical Center provide English-speaking coordinators and endocrinologists. Access is unrestricted for all medical tiers, though costs vary significantly based on residency and National Health Insurance enrollment.
Bookimed Expert Insight: While many patients focus on large tertiary hospitals like Asan, which serves over 11,000 outpatients daily, smaller specialized centers offer unique advantages. For instance, RE:YOUTH in Cheonan provides niche treatments like arterial stem cell therapy for diabetes. Choosing these specialized clinics can often mean more personalized coordination compared to the high-volume environment of major Seoul university hospitals.
Patient Consensus: Patients note that while visiting major hospitals is highly efficient, those without local insurance should expect to pay around $100 for initial consultations. Many recommend using translation apps in smaller clinics and highlight that obtaining the Alien Registration Card significantly simplifies long-term medication management.
Bariatric surgery is a standard treatment for Type 2 diabetes in South Korea, often referred to as metabolic surgery. National healthcare guidelines and the National Health Insurance Service (NHIS) recognize procedures like Roux-en-Y gastric bypass and sleeve gastrectomy for patients with a BMI over 27.5 kg/m² and uncontrolled diabetes.
Bookimed Expert Insight: Specialist experience is the strongest predictor of success in Korean metabolic surgery. Dr. Yongjin Kim at Soon Chun Hyang University Hospital was Korea's first SRC-certified Master Surgeon. He has performed over 2,000 bariatric procedures. Our data shows that while many clinics focus on general surgery, seeking a dedicated Metabolic & Bariatric Surgery Center ensures access to multidisciplinary teams specialized in diabetic remission.
Patient Consensus: Patients note that while surgery leads to significant diabetes improvement, the process is often conservative. Many emphasize the need for professional translators to navigate the strict 12-week pre-surgical weight loss requirements often mandated by local protocols.
KDA guidelines for Type 2 diabetes prioritize a 5% weight reduction through a 500–750 kcal daily deficit and 150 minutes of weekly aerobic activity. Management focuses on high-quality carbohydrates, limiting sodium to 2,300 mg, and strength training twice weekly to maintain insulin sensitivity and glycemic control.
Bookimed Expert Insight: South Korean metabolic centers emphasize surgical intervention when lifestyle changes alone plateau. Dr. Yongjin Kim at Soon Chun Hyang University Hospital has performed over 2,000 bariatric surgeries. This high volume suggests that for patients with morbid obesity, clinical guidelines often transition from 5% weight loss targets to procedural solutions to achieve long-term HbA1c remission.
Patient Consensus: Patients note it is helpful to use KDA apps for tracking 10,000 daily steps. Many find success by adjusting rice-to-vegetable ratios and sharing meals with family to maintain dietary consistency.